Product Images Deferoxamine Mesylate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 3 images provide visual information about the product associated with Deferoxamine Mesylate NDC 60505-6237 by Apotex Corp., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

2gm-vial - 2gm vial

2gm-vial - 2gm vial

This is a pharmaceutical product used for SC, IM, or IV injection. It is a single-dose product and the package contains directions on how to reconstitute it. It should be stored at a controlled room temperature of 20° to 25°C. The product contains Deferoxamine Mesylate and has a net weight of 2 g per vial. It is manufactured by Gland Pharma Limited in Hyderabad, India, for Apotex Corp in Weston, FL, USA. The lot number is 10¥AP/RR/S7/E/R and the NDC is 60505-6237-0. The GTN number is 1030505623706. The product warns against using turbid solutions and also advises discarding unused portions.*

500mg-vial - 500mg vial

500mg-vial - 500mg vial

Deferoxamine Mesylate for Injection, USP is a medication that can be used for subcutaneous, intramuscular, or intravenous administration. The NDC number for this medication is 60505-6236-0 and it is manufactured by a company called Gland Pharma Limited in Hyderabad, India. The medication is intended to be reconstituted prior to use and should be stored at a controlled room temperature. Specific cautionary instructions are provided on the packaging. The medication is distributed in a package that includes a 2D barcode which can be used for online tracking.*

Deferoxamine01 - Deferoxamine01

Deferoxamine01 - Deferoxamine01

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.